Bevacizumab
Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Bevacizumab and local guidelines before prescribing.
VEGF inhibitor
Mechanism
VEGF monoclonal antibody.
Uses
Colorectal, lung, ovarian, renal and cervical cancers, glioblastoma.
Dosing
No dose is given in the chapters. See the BNF.
Side effects
Hypertension, proteinuria, bleeding, GI perforation, impaired wound healing, thrombosis.
Interactions
Anticoagulants increase bleeding risk.
Contraindications and cautions
Recent surgery or wound healing problem
Monitoring
BP, urine protein
Pregnancy and breastfeeding
Contraindicated
Renal and hepatic impairment
No adjustment
Overdose and reversal
Supportive
Special advice
Stop before surgery; check BP and urine protein each cycle.
More from the textbook: uses, cautions and other points
- Atezolizumab plus bevacizumab , or durvalumab plus tremelimumab (first line).
Gastroenterology: Cirrhosis and Transplantation - Atezolizumab + bevacizumab | First-line advanced HCC (Child–Pugh A); check varices before bevacizumab.
Gastroenterology: Cirrhosis and Transplantation - Hypertension and proteinuria on bevacizumab | Anti-VEGF toxicity
Oncology: Principles - Check for varices before bevacizumab (bleeding risk).
Gastroenterology: Cirrhosis and Transplantation - NF2-related schwannomatosis (chromosome 22) | Bilateral vestibular schwannomas (hearing loss, tinnitus, imbalance), meningiomas, spinal tumours, early cataracts. Few skin signs. Bevacizumab for growing schwannomas
Neurology: Spine and Sleep Disorders - Glomerular disease | NSAIDs (minimal change, membranous), penicillamine and gold (membranous), hydralazine and propylthiouracil (ANCA vasculitis), pamidronate (FSGS), VEGF inhibitors such as bevacizumab (proteinuria, hypertension)
Renal: Anatomy, Physiology and Pharmacology - Bevacizumab , and TKIs such as sunitinib, pazopanib, cabozantinib, lenvatinib.
Oncology: Principles - Bevacizumab | Hypertension, proteinuria, perforation, poor wound healing.
Oncology: Principles
Where it is discussed in the book
- Gastroenterology: Cirrhosis and Transplantation (3 mentions)
- Neurology: Spine and Sleep Disorders (1 mention)
- Renal: Anatomy, Physiology and Pharmacology (1 mention)
- Oncology: Principles (3 mentions)
- Oncology: Breast and Gynae Cancers (2 mentions)
- ENT: Common Ear disorders (1 mention)
- Clinical Genetics: Single-gene, repeat-expansion and mitochondrial disorders (2 mentions)
- Cell Biology: Cell cycle, signalling, cell death and stem cells (1 mention)
- Pathology: Neoplasia - tumour biology, spread, staging and markers (1 mention)